Collegium Pharmaceutical Inc (COLL)
ROA
Obliczenia
|
2023 (31 gru 2023) |
2022 (31 gru 2022) |
2021 (31 gru 2021) |
2020 (31 gru 2020) |
2019 (31 gru 2019) |
||
|---|---|---|---|---|---|---|
| Zysk netto | w tys. USD | 48 155 | -25 002 | 71 517 | 26 752 | -22 722 |
| Aktywa razem | w tys. USD | 1 143 310 | 1 174 130 | 692 077 | 643 841 | 306 302 |
| ROA | 4,21% | -2,13% | 10,33% | 4,16% | -7,42% |
2023 obliczenia
ROA = Zysk netto ÷ Aktywa razem
= $48 155K ÷ $1 143 310K
= 4,21%
Analiza porównawcza
2023
Nazwa spółki
Symbol
ROA
Collegium Pharmaceutical Inc
COLL
4,21%
Amphastar Pharmaceuticals Inc
AMPH
9,09%
Arcus Biosciences Inc
RCUS
-28,04%
Catalyst Pharmaceuticals Inc
CPRX
15,19%
Dynavax Technologies Corp.
DVAX
-0,64%
Innoviva Inc
INVA
14,45%
Ironwood Pharmaceuticals Inc
IRWD
-212,76%
Ligand Pharmaceuticals, Inc.
LGND
6,63%
Medifast Inc
MED
32,08%
Myriad Genetics, Inc.
MYGN
-22,97%
Xencor Inc
XNCR
-13,23%